tbResList Print — Calc Calcium

Description: <p><b>Calcium</b> — Calcium is an essential divalent cation and ubiquitous second messenger that supports membrane excitability, secretion, coagulation, contraction, mitochondrial function, and cell-fate signaling. In oncology, its relevance is primarily as a tightly homeostatically controlled signaling ion rather than a conventional anticancer drug. Formal classification: essential mineral; electrolyte; signaling ion; nutrient/supplement, with a separate locoregional interventional use in <i>calcium electroporation</i> (typically intratumoral calcium chloride plus electric pulses). Standard abbreviation: Ca; biologically active species: Ca²⁺. Most body calcium is stored in bone, while the small ionized extracellular pool mediates signaling; this tight systemic regulation is a major translational constraint because oral or routine supplemental calcium does not usually generate tumoricidal intracellular calcium overload. The clearest direct anticancer deployment is local calcium electroporation, whereas broader anticancer effects from dietary or supplemental calcium remain context-dependent and are strongest for colorectal-risk associations rather than established systemic therapy.</p>
<p><b>Primary mechanisms (ranked):</b></p>
<ol>
<li>Ca²⁺ homeostasis dysregulation controlling proliferation, survival, and cell-cycle signaling through channels, pumps, exchangers, and Ca²⁺-dependent transcription programs.</li>
<li>Store-operated calcium entry and related channel remodeling (for example STIM/Orai/TRP-linked influx), supporting migration, invasion, EMT plasticity, and therapy resistance in many tumors.</li>
<li>Mitochondrial Ca²⁺ overload and energetic collapse, especially when intracellular calcium is forcibly increased, driving ATP depletion, permeability transition, and cell death.</li>
<li>Ca²⁺-dependent regulation of adhesion, motility, and cytoskeletal remodeling, influencing metastatic behavior.</li>
<li>Colonic luminal binding of bile acids/fatty acids plus mucosal differentiation effects, a mechanistically plausible but organ-specific chemopreventive axis for colorectal neoplasia.</li>
<li>Immune and stromal signaling effects are relevant but secondary and highly context-dependent.</li>
</ol>
<p><b>Bioavailability / PK relevance:</b> Oral calcium is absorbed by active vitamin-D-dependent transport and passive diffusion; fractional absorption falls as dose rises. Serum total calcium and ionized calcium are kept within narrow ranges by intestinal absorption, bone buffering, and renal handling, so systemic exposure is tightly clamped. Supplement form matters: calcium carbonate is acid/meal dependent, while calcium citrate is less so. For direct anticancer use, delivery is the main issue: local intratumoral calcium plus electroporation can create abrupt intracellular overload, whereas standard oral supplementation generally cannot.</p>
<p><b>In-vitro vs systemic exposure relevance:</b> This is a major limitation. Many in-vitro anticancer experiments use extracellular calcium conditions or electroporation-enabled intracellular loading that exceed what can be achieved safely through ordinary dietary or supplement use. Physiologic ionized serum calcium is only about 1.15–1.33 mmol/L, and homeostasis strongly resists sustained elevation. Thus, concentration-driven tumor kill is generally not achievable systemically without toxicity; calcium electroporation is the main exception because it bypasses the membrane barrier locally.</p>
<p><b>Clinical evidence status:</b> <b>Systemic calcium supplementation:</b> no established direct anticancer treatment role; evidence is mainly observational or chemopreventive, strongest for colorectal-risk reduction signals but not sufficient to regard calcium as a validated systemic anticancer therapy. <b>Calcium electroporation:</b> small human studies, including phase I/II and randomized comparisons versus electrochemotherapy for cutaneous/subcutaneous lesions, support feasibility, local response activity, and generally favorable tolerability, but this remains a niche locoregional approach rather than standard broad oncology care.</p>


<h3>Mechanistic profile</h3>
<table border="1" cellpadding="4" cellspacing="0">
<tr>
<th>Rank</th>
<th>Pathway / Axis</th>
<th>Cancer Cells</th>
<th>Normal Cells</th>
<th>TSF</th>
<th>Primary Effect</th>
<th>Notes / Interpretation</th>
</tr>
<tr>
<td>1</td>
<td>Intracellular Ca2+ homeostasis remodeling</td>
<td>Ca2+ oscillations/signaling rewired; survival and proliferation programs ↑</td>
<td>Physiologic Ca2+ signaling maintained within narrow range</td>
<td>R/G</td>
<td>Growth control</td>
<td>Foundational axis in cancer biology; tumors often remodel channels, pumps, and exchangers to favor survival, proliferation, and adaptation.</td>
</tr>
<tr>
<td>2</td>
<td>Store-operated Ca2+ entry and channel toolkit</td>
<td>STIM/Orai/TRP-linked influx ↑; migration, invasion, EMT, resistance ↑</td>
<td>Required for normal signaling but less oncogenically exploited</td>
<td>R/G</td>
<td>Motility and plasticity</td>
<td>One of the main therapeutically discussed calcium axes; relevance is high, but this usually argues for targeting calcium-handling machinery rather than giving systemic calcium.</td>
</tr>
<tr>
<td>3</td>
<td>Mitochondrial Ca2+ overload and MPTP</td>
<td>Ca2+ overload ↑; mitochondrial dysfunction ↑; ATP ↓; cell death ↑</td>
<td>Better buffering and recovery capacity ↔/less affected</td>
<td>P/R</td>
<td>Energetic collapse</td>
<td>Most directly relevant to calcium electroporation and other forced-loading settings; links calcium excess to permeability transition and necrotic/apoptotic death.</td>
</tr>
<tr>
<td>4</td>
<td>ATP depletion after forced Ca2+ entry</td>
<td>ATP ↓↓↓; viability ↓</td>
<td>ATP ↓ but viability loss typically less pronounced</td>
<td>P/R</td>
<td>Tumoricidal selectivity</td>
<td>A core mechanistic explanation for Ca-electroporation selectivity; acute ATP drain appears central to local antitumor effect.</td>
</tr>
<tr>
<td>5</td>
<td>Adhesion migration cytoskeletal remodeling</td>
<td>Motility/invasion ↑ (context-dependent); metastatic behavior ↑</td>
<td>Normal wound-healing and motility signaling preserved</td>
<td>R/G</td>
<td>Metastatic competence</td>
<td>Calcium signaling intersects with focal adhesion turnover, actomyosin behavior, and epithelial-mesenchymal plasticity.</td>
</tr>
<tr>
<td>6</td>
<td>Colorectal luminal chemoprevention axis</td>
<td>Bile acid and fatty acid irritation ↓; mucosal proliferation ↓; differentiation/apoptosis ↔/↑</td>
<td>Colonic mucosa protection ↑</td>
<td>G</td>
<td>Risk modulation</td>
<td>Organ-specific and preventive rather than therapeutic; strongest mechanistic rationale for colorectal cancer risk reduction, not for established tumor regression.</td>
</tr>
<tr>
<td>7</td>
<td>Immune and stromal calcium signaling</td>
<td>Tumor microenvironment effects ↔ (context-dependent)</td>
<td>Immune-cell activation and stromal signaling depend on Ca2+</td>
<td>R/G</td>
<td>Context modulation</td>
<td>Relevant but not sufficiently specific to rank above direct tumor-cell calcium overload and channel remodeling.</td>
</tr>
<tr>
<td>8</td>
<td>Clinical Translation Constraint</td>
<td>Systemic tumoricidal Ca2+ elevation not feasible</td>
<td>Homeostatic regulation protects normal physiology but limits exposure escalation</td>
<td>G</td>
<td>Delivery limitation</td>
<td>Key constraint: oral/supplemental calcium is tightly regulated; local delivery with electroporation is the clearest way to achieve therapeutically meaningful intracellular overload.</td>
</tr>
</table>
<p>P: 0–30 min</p>
<p>R: 30 min–3 hr</p>
<p>G: &gt;3 hr</p>